Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. (Q40102118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

R A McDonald

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J M Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

M Ho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

R Lindblad

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

D Ikle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

P Grimm

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

M Arar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

D Liereman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

N Bridges

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

W Harmon

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

CCTPT Study Group

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Transplantation

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

984-989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18416737%20AND%20SRC:MED&resulttype=core&format=json

Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02167.X

Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02167.X

Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02167.X

Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02167.X

Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02167.X

Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02167.X

Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02167.X

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02167.X

Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02167.X

American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02167.X